ArticleQuantitative imaging in medicine and surgery2026
A deep learning-based model combining quantitative parameters of initial chest computed tomography and clinical variables for the prediction of posttraumatic acute respiratory distress syndrome.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute respiratory distress syndrome (ARDS) frequently complicates severe trauma, and early risk stratification for this condition remains challenging. This study aimed to develop and internally validate a combined prediction model integrating deep learning-based quantitative parameters of initial chest computed tomography (CT) with clinical variables for the early prediction of posttraumatic ARDS, with a focus on automation and interpretability for potential integration with emergency workflows. Methods: A total of 173 patients with trauma admitted to West China Hospital of Sichuan University from January to June 2024 were retrospectively screened, and 105 patients were finally enrolled (34 in the ARDS group and 71 in the nonARDS group). Clinical data were collected, and quantitative parameters (e.g., opacity score, opacity volume, opacity percentage, highattenuation opacity volume, and mean CT value) were automatically extracted with deep learning-based CT quantitative analysis software. Univariate and multivariate logistic regression analyses were performed to identify factors associated with ARDS. The final multivariate model was expressed as follows: logit(ARDS risk) = -4.623 + [0.142 × Injury Severity Score (ISS)] + [0.247 × procalcitonin (PCT)] + (0.113 × bilateral lung opacity percentage). Model stability was evaluated via bootstrap resampling (1,000 repetitions), and the predictive performance was assessed according to the receiver operating characteristic (ROC) curves. Results: Compared with the non-ARDS group, the ARDS group had a higher ISS (40 Conclusions: Quantitative parameters of initial chest CT within 24 hours after trauma, especially bilateral lung opacity percentage, are associated with the development of ARDS in patients with trauma and may serve as objective imaging biomarkers for early risk assessment. The prediction model combining ISS score and PCT with automated CT quantitative parameters demonstrated good discriminative ability (AUC =0.892) and clinical operability and can be automated within minutes in a research setting. Further implementation studies are needed before the model can be implemented after the initial CT scan in clinical settings; nonetheless, the model may serve as a decision support tool and as a component in implementing early lung-protective strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.